MedPath

Analysis of expression of CD44 and podocalyxin in head and neck cancer

Not Applicable
Recruiting
Conditions
head and neck cancer
Registration Number
JPRN-UMIN000017742
Lead Sponsor
Kumamoto University Graduate School of Medicine
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
50
Inclusion Criteria

Not provided

Exclusion Criteria

patient who reject joining in this trial

Study & Design

Study Type
Others,meta-analysis etc
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Expression of CD44 and podocalyxin in head and neck cancer
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath